Grants and Contributions

The Lindau Nobel Laureate Meetings help promote science and research by fostering the exchange of knowledge, ideas, and experience between and among Nobel Laureates, scientists of different generations, cultures, and disciplines

The objective is to facilitate the SDs continued participation as an active researcher

The specific objective of this funding opportunity are to:

• provide the base/infrastructure funding to the CRISM Phase II Regional Nodes that will allow research teams to organize and collaborate to address critical research in the area of substance use, and to allow them to:
  o identify and develop clinical and community-based prevention or treatment interventions and guidelines, including harm reduction, for substance use
  o provide evidence to decision makers, providers and stakeholders, to support the enhancement of prevention or treatment services, as well as policy development, regarding substance use
  o engage Indigenous Peoples in Canada in research and KT efforts in a manner respecting the rights of Indigenous Peoples and Indigenous self-determination and self-governance, such as following the First Nations Principles of OCAP® (i.e., Ownership, Control, Access and Possession), or employing a distinctions-based approach
  o support the improvement in the quality of care and quality of life for Canadians with substance use disorder
  o involve individuals with lived and living experience throughout the research process
• conduct a Controlled Trial for management of methamphetamine use disorder aligned with the NIDA CTN

The specific objective of this funding opportunity are to:

• provide the base/infrastructure funding to the CRISM Phase II Regional Nodes that will allow research teams to organize and collaborate to address critical research in the area of substance use, and to allow them to:
  o identify and develop clinical and community-based prevention or treatment interventions and guidelines, including harm reduction, for substance use
  o provide evidence to decision makers, providers and stakeholders, to support the enhancement of prevention or treatment services, as well as policy development, regarding substance use
  o engage Indigenous Peoples in Canada in research and KT efforts in a manner respecting the rights of Indigenous Peoples and Indigenous self-determination and self-governance, such as following the First Nations Principles of OCAP® (i.e., Ownership, Control, Access and Possession), or employing a distinctions-based approach
  o support the improvement in the quality of care and quality of life for Canadians with substance use disorder
  o involve individuals with lived and living experience throughout the research process
• conduct a Controlled Trial for management of methamphetamine use disorder aligned with the NIDA CTN

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The CIHR Institute of Human Development, Child and Youth Health (CIHR-IHDCYH) is developing an initiative focused on mental health in the early years. Early childhood, beginning from conception to age five, is a critical period for brain growth and development, including social and emotional development, that lays the foundation for mental health across the lifecycle. Environmental exposures associated with social, economic, and physical environments in which children live, learn and play, can affect brain development with implications for life-long mental health. Therefore, CIHR-IHDCYH will provide one year bridge grants to support research projects that aim to enhance our understanding of factors that can affect early brain development and increase the likelihood of negative mental health outcomes, as well as factors that promote resilience. This will ultimately contribute to the development of enhanced interventions and treatments to optimize mental health in the early years and beyond.

This bridge funding will support research on:

• Mechanisms/factors/environment-gene interactions that affect the developing brain and contribute to negative/positive mental health outcomes in infants and children starting at conception.
• Structural changes to the brain in the context of neurodevelopmental disabilities, neurodivergence, trauma and/or adverse childhood experiences that lead to negative mental health outcomes.
• Preclinical animal models of adverse childhood experiences and neurodevelopmental.
• Biological mechanisms underlying mediators/factors that protect against negative mental health outcomes.
• The inclusion of infants and children in vulnerable, racialized, and under-represented populations, who are disproportionately affected by mental health challenges, is encouraged (as appropriate).

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.